PC
Last reporting period 31 Dec, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
14.221
Exchange
XNAS - Nasdaq
-0.13 B
Last period CFO ,USD
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Vaxcyte
Company Analysis
PCVX valuation, rating, competitors, insights and company profile
Eyestock Rating
PCVX financial analysis by Eyestock methodology
Valuation
PCVX valuation using historical relative method
Statements
PCVX Income Statements, Balance Sheet and Cash Flow Statements
Dividends
PCVX dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Vaxcyte`s CFO for the period ended 2023-12-31 is -0.13 B USD
